ESS team is trash

ess is a running joke in our district. They are literally NEVER heard or seen. It's like they don't exist and the numbers reflect that.

 

Realign coming. It was on the Ask TC. Long overdue, finally!

 

If your smart you will leave ESS voluntarily.

 

87k views? Wow, what a cluster. Seems appropriate.

 

Those people are the true problem. Their baby is ugly and they will get their panties twisted if you speak any truth to them. Cut it off at the head, get rid of the yes men.

 

Reps are dropping like flies, just waited long enough to "earn" their Q4 bonus. More departures on the horizon. Without the DSS help, ESS has no impact.

 

Watch ESS sink on their own now that no one else is incentivized to help them. It's the beginning of the end for them. And a long time overdue.

 

ESS is just another prime example of an attempt by someone in leadership to come up with any idea that they can claim as theirs. It doesn't matter that it is a bad idea or a failed idea because they will be promoted before anyone can accurately measure just how bad their idea failed.
Then they will blame it on the lack of execution by the very sales force that they were praising a short time before. This shit has played out so many times at AZ. There are even examples where the person who originated the idea is successful in pinning it on someone else because all of the major players have changed or are complicit in the crime. This is without a doubt the most fucked up culture where the worst get promoted and the producers get fucked.

 

Spot on. Half the people I know who were forced over from BMS want out, or already got out. AZ is toxic.

 

Yes and no. This has been covered on this thread, lol, what hasn't? This ESS experiment came to be because of the slow start the Bydureon launch had. It was well below the over optimistic projections and could not have anything to do with the inj site nodules, ridiculous tray and big needle. No, it had to do with the sales force. So, the genius who helmed the Amylin sales team was brought in to save the day. Todd Snook was the guy who could save the diabetes franchise. His former Amylin reps were the best, most highly trained pros in pharma sales. How could they trust endos to mere mortals after all. So how is that working for you Todd? Bizarre metrics and smoke and mirrors account for the "success" they claim but in reality no one has been able to do much with this dog of a product. Look at national share.
So when you say the will blame it on the sales force you are partly right. They will blame the failure on the rest of the sales force, not ESS. They will blame lack of cooperation on us and they will scapegoat anyone who was a part of the shit show of a launch pre-ESS. Please end this now.

 

ESS was the solution to a problem - but the powers that be didn't really understand the problem itself. The surveys said that the company didn't have the same respect and cache as Novo, Lilly and Sanofi in the Endo space. So, they wanted to fix that by giving them more and "higher level" attention, while also believing that winning at Endos would result in even more adoption across primary care.

Turns out the more-accessible less-sophisticated primary care doctors were often much easier convince early in the product launches and led the way in adoption themselves.The idea that AZ could show up at Endos just because they now had a big portfolio of 2nd in class non-insulin products and demand respect isn't something that happens overnight - if ever. These doctors have been building relationships with the insulin companies - through product use and broad educational support - often for decades. They just have way more insulin patients than non-insulin patients and the Titanic isn't turning around quickly. But we wanted quick results in both market share and respect - and it showed.

So when we quit having ESS, everyone who has been paying attention sees the real problem: AZ isn't willing to make the long-term, high-cost commitment to earn the respect they so desire. We're a two-trick pony who bought enough assets to call themselves a diabetes company, but can't figure out how to buy the reputation they want.

 

Sending new reps into Specialists who called themselves "Specialty" accomplished absolutely nothing. All this was done to mirror the competition. Let the local DSS teams do their jobs, focus where the business is, where the volume lies and where their relationships will increase sales. END the ESS experiment while there is still some face to save.

 

Will they end ESS now that BJ (was forced out) decided to leave?

It was his dumb ass idea.

 

ESS reps have, and will continue to doom the trajectory of diabetes.

 

Amen!

 

They are asking for help. And we are saying yes. But we are just checking the box. That ship sailed a long time ago specialty.

 

Failed leadership from the start

 

That ship done sunk.

 

Long way to the bottom, apparently.

 

Great call this morning, no wonder we are in trouble!